Location History:
- Griesheim, DE (2012 - 2014)
- Griesham, DE (2014)
Company Filing History:
4 out of 2,945 
1 out of 1,248 
Years Active: 2012-2014
Title: The Innovations of Hans Peter Buchstaller
Introduction
Hans Peter Buchstaller is a notable inventor based in Griesheim, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of HSP90 inhibitors. With a total of 5 patents, his work has the potential to impact the treatment of various diseases.
Latest Patents
Among his latest patents are novel quinazoline derivatives, which are designed as HSP90 inhibitors. These compounds can be utilized in the preparation of medicaments aimed at treating diseases where the inhibition, regulation, and modulation of HSP90 are crucial. Another significant patent involves a triazole derivative, specifically 5-[4-(2-Methylphenyl)-3-hydroxy-4H-1,2,4-triazol-5-yl]-2,4-dihydroxy-N-methyl-N-butylbenzamide, which also serves as an HSP90 inhibitor.
Career Highlights
Hans Peter Buchstaller has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his expertise in patent development and medicinal chemistry.
Collaborations
Throughout his career, Buchstaller has collaborated with notable colleagues such as Hans Michael Eggenweiler and Christian Sirrenberg. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Hans Peter Buchstaller's contributions to the field of medicinal chemistry, particularly through his patents on HSP90 inhibitors, highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in medicine.